CCR3 is a target for age-related macular degeneration diagnosis and therapy-Reference-Cited by-同舟云学术

CCR3 is a target for age-related macular degeneration diagnosis and therapy

Published:2009-06-14 Issue:7252 Volume:460 Page:225-230
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Takeda Atsunobu,Baffi Judit Z.,Kleinman Mark E.,Cho Won Gil,Nozaki Miho,Yamada Kiyoshi,Kaneko Hiroki,Albuquerque Romulo J. C.,Dridi Sami,Saito Kuniharu,Raisler Brian J.,Budd Steven J.,Geisen Pete,Munitz Ariel,Ambati Balamurali K.,Green Martha G.,Ishibashi Tatsuro,Wright John D.,Humbles Alison A.,Gerard Craig J.,Ogura Yuichiro,Pan Yuzhen,Smith Justine R.,Grisanti Salvatore,Hartnett M. Elizabeth,Rothenberg Marc E.,Ambati Jayakrishna

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature08151.pdf

Reference47 articles.

1. Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S. & Adamis, A. P. Age–related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol. 48, 257–293 (2003)

2. Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M. & Guyer, D. R. Pegaptanib for neovascular age-related macular degeneration. N. Engl. J. Med. 351, 2805–2816 (2004)

3. Brown, D. M. et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1432–1444 (2006)

4. Rosenfeld, P. J. et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419–1431 (2006)

5. Famiglietti, E. V. et al. Immunocytochemical localization of vascular endothelial growth factor in neurons and glial cells of human retina. Brain Res. 969, 195–204 (2003)

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating Chemokine-Induced NF-κB Activation in Retinal Cells and Its Contribution to Age-Related Macular Degeneration Pathogenesis: A Systematic Review;2024-09-08

2. Neutrophils in Ocular Diseases;International Journal of Molecular Sciences;2024-07-15

3. CCL11 released by GSDMD-mediated macrophage pyroptosis regulates angiogenesis after hindlimb ischemia;Cell Death Discovery;2024-06-21

4. Novel CCR3-targeted cyclic peptides as potential therapeutic agents for age-related macular degeneration via inhibiting angiogenesis and reducing retinal photoreceptor damage;Bioorganic Chemistry;2024-06

5. Therapeutic targeting of telomerase ameliorates experimental choroidal neovascularization;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06